The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...

The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water.

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

If you're looking for a larger canvas for reading, sketching, gaming, or just about anything else, you're likely much better off going with a tablet. This lets your smartphone keep doing what it ...

Tablets may not be the trendiest devices in 2025, but they remain excellent tools for streaming movies, playing games, or getting work done on the go. While the best iPads continue to dominate the ...

Like many others, I occasionally struggle to sleep. I took this trending sleep supplement for a few weeks to see if it would ...

Patients receiving double-drug hypolipidaemic treatment should be carefully monitored to avoid possible severe complications.

Cholesterol, a lipid naturally processed by the liver, is an essential component of the human body. Yet, it has a bad ...

Pitavastatin is a novel statin that induces plaque regression and is non-inferior to atorvastatin and, on some measures, superior to simvastatin and to pravastatin in the elderly. Pitavastatin ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Though information on a potential sequel is scarce, there are scattered morsels of ...

Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...